Insulin aspart, recombinant Subcutaneous and Nalmefene Hydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nalmefene Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nalmefene
Brand name: Revex
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nalocet
- Insulin aspart, recombinant Subcutaneous-Naloxegol
- Insulin aspart, recombinant Subcutaneous-Naloxegol Oxalate
- Insulin aspart, recombinant Subcutaneous-Naloxone
- Insulin aspart, recombinant Subcutaneous-Naloxone and pentazocine
- Insulin aspart, recombinant Subcutaneous-Naloxone Auto-Injection
- Nalmefene Hydrochloride-Insulin degludec
- Nalmefene Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Nalmefene Hydrochloride-Insulin Degludec (U-100) Vials
- Nalmefene Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Nalmefene Hydrochloride-Insulin degludec and liraglutide
- Nalmefene Hydrochloride-Insulin degludec and liraglutide Subcutaneous